TP53 and neoplasm: Contrastingly, mutations in genes involved in the p53 pathway were significantly higher in IAC compared to AIS and MIA (40% vs. 5% vs. 6%; P < 0.01), indicating the role of the p53 pathway in tumor invasion and malignant progression.